Yüklüyor......
Autophagy activation promotes bevacizumab resistance in glioblastoma by suppressing Akt/mTOR signaling pathway
Glioblastomas are the most common primary and malignant brain tumors. The standard therapy includes surgery and radiotherapy plus chemotherapy, with additional bevacizumab to block the angiogenesis in tumors. However, the ever-growing tolerance of glioblastomas to chemotherapeutic drugs impairs the...
Kaydedildi:
| Yayımlandı: | Oncol Lett |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
D.A. Spandidos
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5774481/ https://ncbi.nlm.nih.gov/pubmed/29434840 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.7446 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|